Copyright
©2010 Baishideng Publishing Group Co.
World J Cardiol. Dec 26, 2010; 2(12): 403-407
Published online Dec 26, 2010. doi: 10.4330/wjc.v2.i12.403
Published online Dec 26, 2010. doi: 10.4330/wjc.v2.i12.403
Drugs | Discharge dose (adults) | Tapering (wait until symptom free and normal CRP) | Monitoring/follow-up (in addition to follow-up for the clinical condition) |
Acetylsalicylic acid (preferred for patients with known atherosclerosis) | 650 mg po qid for 1-2 wk (2-4 wk when recurring) | Taper the dose by 30 % every 1-2 wk then stop | -Use gastric protection |
Ibuprofen | 600 mg po tid for 1-2 wk (2-4 wk when recurring) | Taper the dose by 30 % every 1-2 wk then stop | -Use gastric protection |
Indomethacin | 50 mg po tid for 1-2 wk (2-4 wk when recurring) | Taper the dose by 30 % every 1-2 wk then stop | -Use gastric protection |
Colchicine | 0.5 mg (or 0.6 mg) po bid for 3 mo (6 mo when recurring) | - | -Adjust for renal function |
Use 0.5 mg (or 0.6 mg) po daily in patients intolerant to higher doses, over 70 yr old or less than 70 kg | -AST ALT CK, creatinine initially, then at 1 mo | ||
Prednisone | 0.2-0.5 mg/kg po daily for 2 wk (2-4 wk when recurring) | -Taper the dose by 10% every 1-2 wk | -Osteoporosis prophylaxis |
-Taper slowly, especially when it comes to 15 mg/d, where decreases could be as low as 1.0 mg/d every 6 wk |
- Citation: Farand P, Bonenfant F, Belley-Côté EP, Tzouannis N. Acute and recurring pericarditis: More colchicine, less corticosteroids. World J Cardiol 2010; 2(12): 403-407
- URL: https://www.wjgnet.com/1949-8462/full/v2/i12/403.htm
- DOI: https://dx.doi.org/10.4330/wjc.v2.i12.403